Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Triebel

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Interleukin-2 production after blood transfusions in prospective kidney transplant recipientsJ C Gluckman, D Klatzmann, F Triebel, et al.
The Journal of Clinical Investigation|April 1, 1994
Direct evidence to support the immunosurveillance concept in a human regressive melanomaA Mackensen, G Carcelain, S Viel, et al.
International Journal of Cancer|February 15, 1986
Media conditioned by human leukemic T-cells induce expression of IL2 receptors and proliferation of normal T lymphocytesC Kosmatopoulos, M Allouche, F Triebel, et al.
European Journal of Immunology|December 1, 1988
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytesF Triebel, F Faure, F Mami-Chouaib, et al.
The Journal of Experimental Medicine|November 1, 1994
Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytesF Davodeau, M A Peyrat, J Gaschet, et al.
Journal of Autoimmunity|December 1, 1993
In-situ preferential usage of V alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoidH Michalaki, S Roman-Roman, J F Nicolas, et al.
Molecular Immunology|November 1, 1990
Cloning and expression of a lymphocyte activation gene (LAG-1)E Baixeras, S Roman-Roman, S Jitsukawa, et al.
Clinical and Experimental Immunology|November 1, 1990
Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gammaF Farace, C Mathiot, M Brandely, et al.
The Journal of Experimental Medicine|August 1, 1992
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigensE Baixeras, B Huard, C Miossec, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997
Characterization of the major histocompatibility complex class II binding site on LAG-3 proteinB Huard, R Mastrangeli, P Prigent, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Interleukin-2 production after blood transfusions in prospective kidney transplant recipientsJ C Gluckman, D Klatzmann, F Triebel, et al.
The Journal of Clinical Investigation|April 1, 1994
Direct evidence to support the immunosurveillance concept in a human regressive melanomaA Mackensen, G Carcelain, S Viel, et al.
International Journal of Cancer|February 15, 1986
Media conditioned by human leukemic T-cells induce expression of IL2 receptors and proliferation of normal T lymphocytesC Kosmatopoulos, M Allouche, F Triebel, et al.
European Journal of Immunology|December 1, 1988
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytesF Triebel, F Faure, F Mami-Chouaib, et al.
The Journal of Experimental Medicine|November 1, 1994
Surface expression of functional T cell receptor chains formed by interlocus recombination on human T lymphocytesF Davodeau, M A Peyrat, J Gaschet, et al.
Journal of Autoimmunity|December 1, 1993
In-situ preferential usage of V alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoidH Michalaki, S Roman-Roman, J F Nicolas, et al.
Molecular Immunology|November 1, 1990
Cloning and expression of a lymphocyte activation gene (LAG-1)E Baixeras, S Roman-Roman, S Jitsukawa, et al.
Clinical and Experimental Immunology|November 1, 1990
Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gammaF Farace, C Mathiot, M Brandely, et al.
The Journal of Experimental Medicine|August 1, 1992
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigensE Baixeras, B Huard, C Miossec, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997
Characterization of the major histocompatibility complex class II binding site on LAG-3 proteinB Huard, R Mastrangeli, P Prigent, et al.
Pageof 12